Global Certificate in Pharma Supply Chain Risk Prevention
-- ViewingNowThe Global Certificate in Pharma Supply Chain Risk Prevention is a comprehensive course that addresses the growing need for risk management in the pharmaceutical industry. This course highlights the importance of identifying, assessing, and mitigating potential threats to the pharmaceutical supply chain, thereby ensuring the continuity of critical operations and maintaining patient safety.
7,428+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ě´ ęłźě ě ëí´
100% ě¨ëźě¸
ě´ëěë íěľ
ęłľě ę°ëĽí ě¸ěŚě
LinkedIn íëĄíě ěśę°
ěëŁęšě§ 2ę°ě
죟 2-3ěę°
ě¸ě ë ěě
ë기 ę¸°ę° ěě
ęłźě ě¸ëśěŹí
Here are the essential units for a Global Certificate in Pharma Supply Chain Risk Prevention:
• Introduction to Pharma Supply Chain Risk Prevention: Understanding the primary risks and challenges involved in the pharmaceutical supply chain, and the importance of risk prevention strategies in ensuring patient safety and business continuity.
• Supply Chain Management Fundamentals: Learning the basics of supply chain management, including supply chain design, logistics, and distribution, and how they apply to the pharmaceutical industry.
• Risk Identification and Assessment: Identifying and assessing potential risks in the pharma supply chain, including supply disruptions, quality issues, and security threats, using tools and techniques such as risk matrices, failure mode and effects analysis (FMEA), and hazard analysis and critical control points (HACCP).
• Risk Mitigation and Prevention Strategies: Developing and implementing effective risk mitigation and prevention strategies, such as supplier evaluation and selection, quality control measures, and contingency plans, to minimize the impact of supply chain risks on the business.
• Regulatory Compliance and Standards: Understanding the regulatory frameworks and standards that apply to the pharmaceutical supply chain, including Good Distribution Practice (GDP), the Food and Drug Administration (FDA) regulations, and the European Medicines Agency (EMA) guidelines, and how to ensure compliance.
• Supply Chain Visibility and Traceability: Implementing supply chain visibility and traceability systems to monitor and control the flow of goods and information, and to detect and respond to supply chain disruptions in real-time.
• Crisis Management and Business Continuity Planning: Developing and implementing crisis management and business continuity plans to minimize the impact of supply chain disruptions on the business, and to ensure the continuity of operations and patient care.
• Case Studies and Real-Life Examples: Analyzing real-life examples and case studies of pharma supply chain risk prevention, and applying the lessons learned to improve the res
ę˛˝ë Ľ 경ëĄ
ě í ěęą´
- 죟ě ě ëí 기본 ě´í´
- ěě´ ě¸ě´ ëĽěë
- ěť´í¨í° ë° ě¸í°ëˇ ě ꡟ
- 기본 ěť´í¨í° 기ě
- ęłźě ěëŁě ëí íě
ěŹě ęłľě ěę˛Šě´ íěíě§ ěěľëë¤. ě ꡟěąě ěí´ ě¤ęłë ęłźě .
ęłźě ěí
ě´ ęłźě ě ę˛˝ë Ľ ę°ë°ě ěí ě¤ěŠě ě¸ ě§ěęłź 기ě ě ě ęłľíŠëë¤. ꡸ę˛ě:
- ě¸ě ë°ě 기ę´ě ěí´ ě¸ěŚëě§ ěě
- ęśíě´ ěë 기ę´ě ěí´ ęˇě ëě§ ěě
- ęłľě ě겊ě ëł´ěě
ęłźě ě ěąęłľě ěźëĄ ěëŁí늴 ěëŁ ě¸ěŚě뼟 ë°ę˛ ëŠëë¤.
ě ěŹëë¤ě´ ę˛˝ë Ľě ěí´ ě°ëŚŹëĽź ě ííëę°
댏롰 ëĄëŠ ě¤...
ě죟 돝ë ě§ëŹ¸
ě˝ě¤ ěę°ëŁ
- 죟 3-4ěę°
- 쥰기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- 죟 2-3ěę°
- ě 기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- ě 체 ě˝ě¤ ě ꡟ
- ëě§í¸ ě¸ěŚě
- ě˝ě¤ ěëŁ
ęłźě ě ëł´ ë°ę¸°
íěŹëĄ ě§ëś
ě´ ęłźě ě ëšěŠě ě§ëśí기 ěí´ íěŹëĽź ěí ě˛ęľŹě뼟 ěě˛íě¸ě.
ě˛ęľŹěëĄ ę˛°ě ę˛˝ë Ľ ě¸ěŚě íë
